Cassava Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 90.71. In total, the insiders bought 6.47M and sold 141.6K SAVA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
90.71
Buy 6.47M shares
Sell 141.6K shares
92% Buy Activity
Weak Negative Correlation
Buy Signal High Confidence
May 26, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 90.71.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date Type Person Role Amount
Nov 18, 2024
Buy
Common Stock
J-Other
Nassif Freda
Officer
Officer 0
Value: $0
Nov 18, 2024
Buy
Common Stock
J-Other
Nassif Freda
Officer
Officer 0
Value: $0
Nov 18, 2024
Buy
Stock Option (Right to Buy)
A-Award
Nassif Freda
Chief Commercial Officer
Officer 100 000
Value: $2.80M
Nov 18, 2024
Buy
Stock Option (Right to Buy)
Landen Jaren
Chief Clinical Dev. Officer
Officer 15 000
Value: $398.6K
Nov 18, 2024
Buy
Stock Option (Right to Buy)
A-Award
Landen Jaren
Chief Clinical Dev. Officer
Officer 85 000
Value: $2.38M
Oct 01, 2024
Buy
Stock Option (Right to Buy)
A-Award
Barry Richard
President & CEO
CEO / President 600 000
Value: $16.5M
Oct 01, 2024
Buy
Stock Option (Right to Buy)
A-Award
Barry Richard
President & CEO
CEO / President 600 000
Value: $16.5M
Sep 06, 2024
Buy
Stock Option (Right to Buy)
A-Award
Schoen Eric
Chief Financial Officer
C-Suite Officer 100 000
Value: $2.69M
Sep 06, 2024
Buy
Stock Option (Right to Buy)
A-Award
Cook Robert Christopher
SVP & General Counsel
Officer 100 000
Value: $2.69M
Sep 06, 2024
Buy
Stock Option (Right to Buy)
A-Award
Kupiec James William
Chief Medical Officer
Officer 100 000
Value: $2.69M
Sep 06, 2024
Buy
Stock Option (Right to Buy)
A-Award
Kupiec James William
Chief Medical Officer
Officer 100 000
Value: $2.69M
Sep 06, 2024
Buy
Stock Option (Right to Buy)
A-Award
Cook Robert Christopher
SVP & General Counsel
Officer 100 000
Value: $2.69M
Sep 06, 2024
Buy
Stock Option (Right to Buy)
A-Award
Schoen Eric
Chief Financial Officer
C-Suite Officer 100 000
Value: $2.69M
May 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Barbier Remi
President & CEO
CEO / President 50 000
Value: $1.11M
May 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Schoen Eric
Chief Financial Officer
C-Suite Officer 25 000
Value: $552.5K
May 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Cook Robert Christopher
SVP & General Counsel
Officer 10 000
Value: $221.0K
May 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Kupiec James William
Chief Medical Officer
Officer 10 000
Value: $221.0K
May 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Kupiec James William
Chief Medical Officer
Officer 10 000
Value: $221.0K
May 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Cook Robert Christopher
SVP & General Counsel
Officer 10 000
Value: $221.0K
May 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Schoen Eric
Chief Financial Officer
C-Suite Officer 25 000
Value: $552.5K
May 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Barbier Remi
President & CEO
CEO / President 50 000
Value: $1.11M
May 16, 2024
Sell
Common Stock
G-Gift
Robertson Sanford
Director
Director 5 000
Value: $0
May 16, 2024
Buy
Common Stock
G-Gift
Robertson Sanford
Director
Director 5 000
Value: $0
May 16, 2024
Buy
Common Stock
G-Gift
Robertson Sanford
Director
Director 5 000
Value: $0
May 16, 2024
Sell
Common Stock
G-Gift
Robertson Sanford
Director
Director 5 000
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE